Precipio Inc

Change company Symbol lookup

Select an option...

PRPO Precipio Inc

NEOV NeoVolta Inc

FIISO Financial Institutions Inc

KA Kineta Inc

TCS Container Store Group Inc

MLGO MicroAlgo Inc

INDI indie Semiconductor Inc

JCI Johnson Controls International PLC

FPAY FlexShopper Inc

CMSA CMS Energy Corp

Go

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its technology enables testing to be completed in one rapid scanning process. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.